Let me cool the hot air 'Burningtiger', Stonemason knows what he is talking about and it's always a pleasure to read his posts. As for you, go and get a room with Oxy, Lol. You may not be sure but I am sure that ADMEDUS has the manufacturing capacity as WP explained it in the last interview on market point?
Fact 1) I'm not saying you didn't discuss this with an expert in the field but the Norwood procedure is a major defect at birth with many arteries needing rerouting(Elite specialist only) with not only the 3D Curved Patch but many more little bits and piece's that have to be cut to size for the procedures. So I think you are looking at the wrong market.
Fact 2) Whip your lip because there is something running down your chin. What a load of sh*t, Baxter is out of Vasculcel and they had the majority of the market, NEO is new and improved and the 3D Curved Patch is a revolution to cardiac procedures and outcomes for patients. The statistics are out and other companies are in the same predicament, out.
PS: Knock it on the head.
4th JULY, page-8
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |